Birch pollen allergy vaccine - HAL Allergy

Drug Profile

Birch pollen allergy vaccine - HAL Allergy

Alternative Names: SUBLIVAC FIX Birch; Sublivac Fix Birch

Latest Information Update: 05 Jul 2016

Price : $50

At a glance

  • Originator HAL Allergy
  • Class Allergens; Antiallergics; Tree pollen allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic rhinitis; Allergic rhinoconjunctivitis

Most Recent Events

  • 30 Apr 2013 HAL Allergy completes a phase II trial in Allergic rhinitis and Allergic rhinoconjunctivitis in Czech Republic, Germany and Poland (NCT01639768)
  • 06 Nov 2012 HAL Allergy completes enrolment in its phase II trial for Allergic rhinitis and Allergic rhinoconjunctivitis in the Czech Republic, Poland and Germany (EudraCT2011-004550-25)
  • 31 Jul 2012 Phase-II clinical trials in Allergic rhinitis in Czech Republic (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top